The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Biomaterial Scaffold Fabrication Techniques for Potential Tissue Engineering Applications
Open accessAbstract
Scaffolds are used to provide sites for cells attachment, proliferation, differentiation and migration by up regulating and down regulating the synthesis of protein and growth factors. They provide mechanical support, deliver inductive molecules or cells to the repair site. Scaffolds also provide cues to control the structure and function of newly formed tissue. Recently decellularized extracellular matrix has been suggested as a scaffold for heart valve tissue engineering or direct implantation. However, cell removal damages the physical and biochemical properties of the valve leaflet structure. Matrix /polymer hybrid scaffold with improved biomechanical characteristics may be advantageous for many tissue engineering aspects such as heart valve tissue engineering (Hao et al., 2008). Equilibrium is needed between highly porous scaffolds that allow rapid tissue ingrowths and minimize diffusion limitations and less porous materials that retain both construct shape and the ability to bear mechanical loads in a complex biochemical and mechanical environment. The incorporation of the bioactive molecules like the growth factor, enzymes, ECM proteins, DNA is another vital consideration while designing the scaffolds. The fabrication methodologies that do not inactivate the biological activity of the bioactive molecule within the scaffolds need to be used judiciously. Scaffolds can be made by different types of fabrication techniques. The fabrication techniques provide the regular architectures; allow mechanical and finite element analyses to be carried out, which permit quantification of suitable mechanical and chemical microenvironments for cells and tissues assisting in the development of the next generation of tissue engineered scaffolds. The fabrication technique for the tissue engineered scaffold is directly related to the bulk and surface properties of the polymer and the proposed function of the scaffold. While each technique has its inherent merits and demerits, the appropriate selection of the methodologies must satisfy the requirements of the specific tissue to be repaired or engineered. Another hindrance in the tissue engineering research and scaffold design is the ignorance of the researchers on the possible interactions that exists between different cell types, such as the communication between the scaffold and the cells seeded within, cells and the different soluble factors, the typical behaviour of cells under the physical forces (shear, compression and vibration forces) The different techniques are developed to improve the current scaffold design by controlling the regular pore size, pore interconnectivity, porosity and pore characterizations that is suitable for rapid nutrient diffusion and cell attachment. Table 1 shows the most commonly used scaffolds fabrication technologies for potential tissue engineering applications indicating their merits and demerits of each technique. Some references given below in this chapter allow interested readers to go through the detail of fabrication techniques. Recent advances in both computational topology design (CTD) and solid free-form fabrication (SFF) have made it possible to create scaffolds with controlled architecture (Hollister, 2005). Finally, future directions are utilization of modelled scaffolds with in vivo experimentation to optimize tissue-engineering treatments, and coupling scaffolds with cells, genes and proteins optimized to create smart scaffolds for tissue regeneration and controlling their delivery through the scaffold with spatial and temporal resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Altman, G. H., Diaz, F., Jakuba, C., Calabro, T., Horan, R. L., Chen, J., Lu, H., Richmond, J., & Kaplan, D. L. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00353-8 · Cited by 3,458
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Alzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
Uchida, K. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00014-6 · Cited by 1,164
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135
Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972
Does oxidative damage to DNA increase with age?
Hamilton, M. L., Van Remmen, H., Drake, J. A., Yang, H., Guo, Z. M., Kewitt, K., Walter, C. A., & Richardson, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171202698 · Cited by 768
Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage.
Shigenaga, M. K., Gimeno, C. J., & Ames, B. N. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9697 · Cited by 732
Morris, M. C. (2002) · JAMA · doi:10.1001/jama.287.24.3230 · Cited by 678
In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams
Lu, L., Peter, S. J., D. Lyman, M., Lai, H.-L., Leite, S. M., Tamada, J. A., Uyama, S., Vacanti, J. P., Langer, R., & Mikos, A. G. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00047-8 · Cited by 668
Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Neuroprotective effects of curcumin
Cole, G. M., Teter, B., & Frautschy, S. A. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_8 · Cited by 516
Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease
Mecocci, P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.794 · Cited by 229
Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease
Bradley, M. A., Markesbery, W. R., & Lovell, M. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.016 · Cited by 193
Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging
Kröger, E., Verreault, R., Carmichael, P.-H., Lindsay, J., Julien, P., Dewailly, É., Ayotte, P., & Laurin, D. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26987 · Cited by 149
A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease
Weyer, G., Babej-Dölle, R. M., Hadler, D., Hofmann, S., & Herrmann, W. M. (2008) · Neuropsychobiology · doi:10.1159/000119366 · Cited by 120
Cited by
Scaffolds for bone tissue engineering: state of the art and new perspectives
Roseti, L., Parisi, V., Petretta, M., Cavallo, C., Desando, G., Bartolotti, I., & Grigolo, B. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.05.017 · Cited by 1,320
A Comparative Review of Natural and Synthetic Biopolymer Composite Scaffolds
Reddy, M. S. B., Ponnamma, D., Choudhary, R., & Sadasivuni, K. K. (2021) · Polymers · doi:10.3390/polym13071105 · Cited by 1,104
PCL and PCL-based materials in biomedical applications
Malikmammadov, E., Tanir, T. E., Kiziltay, A., Hasirci, V., & Hasirci, N. (2018) · Journal of Biomaterials Science, Polymer Edition · doi:10.1080/09205063.2017.1394711 · Cited by 894
Chitosan based bioactive materials in tissue engineering applications-A review
Islam, M. M., Shahruzzaman, M., Biswas, S., Nurus Sakib, M., & Rashid, T. U. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.01.012 · Cited by 611
Vijayavenkataraman, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.003 · Cited by 556
Metadata
- Authors
- Subia, B., Kundu, J., & C., S.
- Venue
- Tissue Engineering
- Publisher
- InTech
- Published
- 2010-03-01
- ISSN
- 1076-3279 (ISSN-L)
- DOI
- 10.5772/8581
- OpenAlex
- W1500442371
- Cited by
- 183
- References
- 17
- FWCI
- 39.17
- Type
- book chapter
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.